Form 4: NovoCure Director Timothy J. Scannell Reports Transactions in Company Stock

Director Timothy J. Scannell reports the sale of 964 ordinary shares and acquisition of 4,053 restricted stock units and 6,229 stock options in NovoCure Ltd.

Summary

• On June 4, 2024, Timothy J. Scannell, a director of NovoCure Ltd, sold 964 ordinary shares at a weighted average price of $23.8874.
• The sale was executed in multiple trades with prices ranging from $23.80 to $23.95.
• On June 5, 2024, Scannell acquired 4,053 restricted stock units.
• These restricted stock units will vest 100% on the earlier of June 5, 2025, or the day before the company's 2025 annual general meeting of shareholders.
• Scannell also acquired options to buy 6,229 ordinary shares on June 5, 2024, at an exercise price of $23.13.
• These options will fully vest and become exercisable on the earlier of June 5, 2025, or the day before the company's 2025 annual general meeting of shareholders.
• Following these transactions, Scannell directly owns 2,964 ordinary shares, 7,981 restricted stock units, and 6,229 stock options.

Sentiment

Score: 6

Explanation: Neutral sentiment as it primarily reports transactions. The sale of shares is slightly negative, but the acquisition of stock options and restricted stock units is a positive sign.

Positives

• The acquisition of restricted stock units and stock options indicates a continued investment and alignment with the company's future performance.

Negatives

• The sale of 964 ordinary shares by a director could be perceived negatively by some investors, although the quantity is relatively small.

Risks

• There are no specific risks mentioned in this document.

Future Outlook

The vesting schedules for the restricted stock units and stock options are tied to the company's 2025 annual general meeting, suggesting a focus on long-term performance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider activity.

Key Dates